TREATMENT OF NEOVASCULAR OCULAR DISEASE STATES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100233194A1
SERIAL NO

12593758

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and regime or regimen for inhibiting unwanted ocular angiogenesis include the treatment of ocular neovascularization by administration of anti-angiogenesis agents, e.g., agents that inhibit VEGF, in combination with a second ocular therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FOVEA PHARMACEUTICALS INSTITUT DE LA VISION17 RUE MOREAU F-75012 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Belichard, Pierre Paris, FR 5 49
Combal, Jean-Philippe Dijon, FR 3 118
Latour, Elisabeth Paris, FR 14 159

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation